Ketostix® and Keto-Diastix® Performance Study

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Urinalysis
Interventions
DEVICE

Testing of self collected urine

Each PWD will test their self-collected urine.

DEVICE

Labeling Evaluation

Each PWD will complete a labeling evaluation.

DEVICE

Urine Control testing

Each PWD will test four urine control solutions.

Trial Locations (1)

21201

University of Maryland, Baltimore

Sponsors
All Listed Sponsors
lead

Ascensia Diabetes Care

INDUSTRY

NCT06053593 - Ketostix® and Keto-Diastix® Performance Study | Biotech Hunter | Biotech Hunter